Cardiol Clin. 2022 Nov;40(4):443-457. doi: 10.1016/j.ccl.2022.06.002. Epub 2022 Sep 1.
ABSTRACT
Heart failure with preserved ejection fraction (HFpEF) is highly prevalent, affecting approximately half of all patients with HF. The diagnosis of HFpEF can be notoriously challenging in clinical practice, given the many overlapping etiologies of dyspnea or reduced exercise tolerance in patients at risk for HFpEF. Multimodality imaging has an important role in establishing the diagnosis of HFpEF and the presence of elevated left ventricular filling pressures, identifying specific etiologies of HFpEF that can benefit from approved therapies, and discerning distinct phenogroups or mechanistic abnormalities that may inform the development of novel therapeutics.
PMID:36210130 | DOI:10.1016/j.ccl.2022.06.002